BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 26563648)

  • 41. Methodological quality and descriptive characteristics of prosthodontic-related systematic reviews.
    Aziz T; Compton S; Nassar U; Matthews D; Ansari K; Flores-Mir C
    J Oral Rehabil; 2013 Apr; 40(4):263-78. PubMed ID: 23330989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid Evidence Assessment of the Literature (REAL(©)): streamlining the systematic review process and creating utility for evidence-based health care.
    Crawford C; Boyd C; Jain S; Khorsan R; Jonas W
    BMC Res Notes; 2015 Nov; 8():631. PubMed ID: 26525982
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early assessment of medical technologies to inform product development and market access: a review of methods and applications.
    Ijzerman MJ; Steuten LM
    Appl Health Econ Health Policy; 2011 Sep; 9(5):331-47. PubMed ID: 21875163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reviewing the evidence to inform the population of cost-effectiveness models within health technology assessments.
    Kaltenthaler E; Tappenden P; Paisley S
    Value Health; 2013; 16(5):830-6. PubMed ID: 23947977
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematic reviews on child welfare services: identifying and disseminating the evidence.
    Kornør H; Bergman H; Maayan N; Soares-Weiser K; Bjørndal A
    J Eval Clin Pract; 2015 Oct; 21(5):855-60. PubMed ID: 26081348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perspectives on systematic review protocol registration: a survey amongst stakeholders in the clinical research publication process.
    van der Braak K; Heus P; Orelio C; Netterström-Wedin F; Robinson KA; Lund H; Hooft L
    Syst Rev; 2023 Dec; 12(1):234. PubMed ID: 38098085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pitfalls in systematic reviews.
    Farquhar C; Vail A
    Curr Opin Obstet Gynecol; 2006 Aug; 18(4):433-9. PubMed ID: 16794425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of existing systematic reviews for evidence assessments in infectious disease prevention: a comparative case study.
    Harder T; Remschmidt C; Haller S; Eckmanns T; Wichmann O
    Syst Rev; 2016 Oct; 5(1):171. PubMed ID: 27724950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methods for Developing Evidence Reviews in Short Periods of Time: A Scoping Review.
    Abou-Setta AM; Jeyaraman MM; Attia A; Al-Inany HG; Ferri M; Ansari MT; Garritty CM; Bond K; Norris SL
    PLoS One; 2016; 11(12):e0165903. PubMed ID: 27930662
    [TBL] [Abstract][Full Text] [Related]  

  • 53. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence-based clinical guidelines in Kyrgyz Republic.
    Zurdinova AA
    Int J Risk Saf Med; 2015; 27 Suppl 1():S45-6. PubMed ID: 26639705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conducting systematic reviews of economic evaluations.
    Gomersall JS; Jadotte YT; Xue Y; Lockwood S; Riddle D; Preda A
    Int J Evid Based Healthc; 2015 Sep; 13(3):170-8. PubMed ID: 26288063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of rapid guidelines: 2. A qualitative study with WHO guideline developers.
    Florez ID; Morgan RL; Falavigna M; Kowalski SC; Zhang Y; Etxeandia-Ikobaltzeta I; Santesso N; Wiercioch W; Schünemann HJ
    Health Res Policy Syst; 2018 Jul; 16(1):62. PubMed ID: 30005710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Few systematic reviews exist documenting the extent of bias: a systematic review.
    Tricco AC; Tetzlaff J; Sampson M; Fergusson D; Cogo E; Horsley T; Moher D
    J Clin Epidemiol; 2008 May; 61(5):422-34. PubMed ID: 18394534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Do policy-makers find commissioned rapid reviews useful?
    Moore G; Redman S; Rudge S; Haynes A
    Health Res Policy Syst; 2018 Feb; 16(1):17. PubMed ID: 29482643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses Disagree.
    Sylvester RJ; Canfield SE; Lam TB; Marconi L; MacLennan S; Yuan Y; MacLennan G; Norrie J; Omar MI; Bruins HM; Hernández V; Plass K; Van Poppel H; N'Dow J
    Eur Urol; 2017 May; 71(5):811-819. PubMed ID: 27914898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paper 2: Performing rapid reviews.
    King VJ; Stevens A; Nussbaumer-Streit B; Kamel C; Garritty C
    Syst Rev; 2022 Jul; 11(1):151. PubMed ID: 35906677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.